These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 18613925

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparative study of two androgen-induced markers (apolipoprotein D and pepsinogen C) in female and male breast carcinoma.
    Serra C, Vizoso F, Lamelas ML, Rodríguez JC, González LO, Merino AM, Baltasar A, Pérez-Vázquez MT, Medrano J.
    Int J Surg Investig; 2000; 2(3):183-92. PubMed ID: 12678518
    [Abstract] [Full Text] [Related]

  • 3. BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients.
    Kwiatkowska E, Teresiak M, Filas V, Karczewska A, Breborowicz D, Mackiewicz A.
    Clin Cancer Res; 2003 Oct 01; 9(12):4452-9. PubMed ID: 14555518
    [Abstract] [Full Text] [Related]

  • 4. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.
    Sharif MA, Mamoon N, Mushtaq S, Khadim MT.
    J Coll Physicians Surg Pak; 2009 Feb 01; 19(2):99-103. PubMed ID: 19208313
    [Abstract] [Full Text] [Related]

  • 5. COX-2 expression does not correlate with microvessel density in breast cancer.
    Thorat MA, Mehrotra S, Morimiya A, Badve S.
    Pathobiology; 2009 Feb 01; 76(1):39-44. PubMed ID: 19188749
    [Abstract] [Full Text] [Related]

  • 6. Steroid hormone receptor expression in male breast cancer.
    Murphy CE, Carder PJ, Lansdown MR, Speirs V.
    Eur J Surg Oncol; 2006 Feb 01; 32(1):44-7. PubMed ID: 16260112
    [Abstract] [Full Text] [Related]

  • 7. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
    Wei B, Wang J, Bourne P, Yang Q, Hicks D, Bu H, Tang P.
    Hum Pathol; 2008 Dec 01; 39(12):1809-15. PubMed ID: 18715613
    [Abstract] [Full Text] [Related]

  • 8. Comparative study of CD34, alpha-SMA and h-caldesmon expression in the stroma of gynaecomastia and male breast carcinoma.
    Kalekou H, Kostopoulos I, Milias S, Papadimitriou CS.
    Histopathology; 2005 Jul 01; 47(1):74-81. PubMed ID: 15982326
    [Abstract] [Full Text] [Related]

  • 9. Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast.
    Gonzalez LO, Corte MD, Junquera S, Bongera M, Rodriguez JC, Vizoso FJ.
    Histopathology; 2007 Jun 01; 50(7):866-74. PubMed ID: 17543076
    [Abstract] [Full Text] [Related]

  • 10. Steroid hormone receptors in male breast diseases.
    Pacheco MM, Oshima CF, Lopes MP, Widman A, Franco EL, Brentani MM.
    Anticancer Res; 1986 Jun 01; 6(5):1013-7. PubMed ID: 3026231
    [Abstract] [Full Text] [Related]

  • 11. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast.
    Honma N, Takubo K, Akiyama F, Sawabe M, Arai T, Younes M, Kasumi F, Sakamoto G.
    Histopathology; 2005 Aug 01; 47(2):195-201. PubMed ID: 16045781
    [Abstract] [Full Text] [Related]

  • 12. Expression and clinical significance of apolipoprotein D in male breast cancer and gynaecomastia.
    Serra Díaz C, Vizoso F, Lamelas ML, Rodríguez JC, González LO, Baltasar A, Medrano J.
    Br J Surg; 1999 Sep 01; 86(9):1190-7. PubMed ID: 10504376
    [Abstract] [Full Text] [Related]

  • 13. Prostate-specific antigen may serve as a pathological predictor in breast cancer.
    Nariţa D, Anghel A, Motoc M.
    Rom J Morphol Embryol; 2008 Sep 01; 49(2):173-80. PubMed ID: 18516323
    [Abstract] [Full Text] [Related]

  • 14. Aromatase and steroid receptors in gynecomastia and male breast carcinoma: an immunohistochemical study.
    Sasano H, Kimura M, Shizawa S, Kimura N, Nagura H.
    J Clin Endocrinol Metab; 1996 Aug 01; 81(8):3063-7. PubMed ID: 8768875
    [Abstract] [Full Text] [Related]

  • 15. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.
    Tezel GG, Uner A, Yildiz I, Guler G, Takahashi M.
    Pathol Res Pract; 2009 Aug 01; 205(6):403-8. PubMed ID: 19232840
    [Abstract] [Full Text] [Related]

  • 16. Clinical and pathological correlations in male breast cancer: intratumoral aromatase expression via tissue microarray.
    Dakin Haché K, Gray S, Barnes PJ, Dewar R, Younis T, Rayson D.
    Breast Cancer Res Treat; 2007 Oct 01; 105(2):169-75. PubMed ID: 17268818
    [Abstract] [Full Text] [Related]

  • 17. CD1a down-regulation in primary invasive ductal breast carcinoma may predict regional lymph node invasion and patient outcome.
    La Rocca G, Anzalone R, Corrao S, Magno F, Rappa F, Marasà S, Czarnecka AM, Marasà L, Sergi C, Zummo G, Cappello F.
    Histopathology; 2008 Jan 01; 52(2):203-12. PubMed ID: 18184269
    [Abstract] [Full Text] [Related]

  • 18. An immunohistochemical study of the long-term effects of androgen administration on female-to-male transsexual breast: a comparison with normal female breast and male breast showing gynaecomastia.
    Burgess HE, Shousha S.
    J Pathol; 1993 May 01; 170(1):37-43. PubMed ID: 8326458
    [Abstract] [Full Text] [Related]

  • 19. Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassification.
    Webster LR, Lee SF, Ringland C, Morey AL, Hanby AM, Morgan G, Byth K, Mote PA, Provan PJ, Ellis IO, Green AR, Lamoury G, Ravdin P, Clarke CL, Ward RL, Balleine RL, Hawkins NJ.
    Clin Cancer Res; 2008 Oct 15; 14(20):6625-33. PubMed ID: 18927304
    [Abstract] [Full Text] [Related]

  • 20. Expression of prolactin and its receptor in human breast carcinoma.
    Reynolds C, Montone KT, Powell CM, Tomaszewski JE, Clevenger CV.
    Endocrinology; 1997 Dec 15; 138(12):5555-60. PubMed ID: 9389544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.